GL1X · GenesisL1 explorer

MolNFT v2 · #100852 · protein

Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide Phosphoribosyltransferase (NAMPT)

4N9C: “Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide…”. X-ray diffraction at 1.751. MolNFT v2 #100852 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4N9C
Type
protein
Length
939 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.751
Source
Homo sapiens
UniProt
P43490

Structure

x-ray diffraction · resolution 1.751 · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein469—P43490
B—protein470—P43490

Compared structures

  • 4N9C · Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.